FDA OKs Roche’s Zelboraf for rare blood disease
admin 8th November 2017 Uncategorised 0US regulators have approved Roche’s Zelboraf (vemurafenib) for patients with a rare blood condition called Erdheim-Chester disease (ECD) carrying a mutation called BRAF V600
More: FDA OKs Roche’s Zelboraf for rare blood disease
Source: News